Talis Biomedical - Stock Price History | TLIS

Historical daily share price chart and data for Talis Biomedical since 2021 adjusted for splits. The latest closing stock price for Talis Biomedical as of September 27, 2021 is 6.58.
  • The all-time high Talis Biomedical stock closing price was 27.80 on February 12, 2021.
  • The Talis Biomedical 52-week high stock price is 33.90, which is 415.2% above the current share price.
  • The Talis Biomedical 52-week low stock price is 5.91, which is 10.2% below the current share price.
  • The average Talis Biomedical stock price for the last 52 weeks is 11.54.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Talis Biomedical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.169B $0.011B
Talis Biomedical Corporation engaged in developing and commercializing products for infectious diseases at the point-of-care. The company involved in developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis Biomedical Corporation is based in MENLO PARK, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29